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ABSTRACT
The degradation of the poly(A) tail is crucial for
posttranscriptional gene regulation and for quality
control of mRNA. Poly(A)-specific ribonuclease
(PARN) is one of the major mammalian 3’ specific
exo-ribonucleases involved in the degradation of
the mRNA poly(A) tail, and it is also involved in the
regulation of translation in early embryonic develop-
ment. The interaction between PARN and the
m
7GpppG cap of mRNA plays a key role in stimulat-
ing the rate of deadenylation. Here we report the
solution structures of the cap-binding domain of
mouse PARN with and without the m
7GpppG cap
analog. The structure of the cap-binding domain
adopts the RNA recognition motif (RRM) with a
characteristic a-helical extension at its C-terminus,
which covers the b-sheet surface (hereafter referred
to as PARN RRM). In the complex structure of PARN
RRM with the cap analog, the base of the N
7-methyl
guanosine (m
7G) of the cap analog stacks with the
solvent-exposed aromatic side chain of the dis-
tinctive tryptophan residue 468, located at the
C-terminal end of the second b-strand. These
unique structural features in PARN RRM reveal a
novel cap-binding mode, which is distinct from the
nucleotide recognition mode of the canonical
RRM domains.
INTRODUCTION
Regulation of mRNA turnover is an important process in
determining the levels of gene expression and the quality
control of mRNA biogenesis (1–3). In eukaryotes, mRNA
turnover is controlled by two factors: the length of the
poly(A) tail at the 30 end of the mRNA and the presence
of the N
7-methyl guanosine (m
7GpppG) cap at its 50 end,
which are involved in maturation, transport, translation
and degradation of the mRNA (4–7). Cytoplasmic mRNA
degradation is initiated by shortening the 30 poly(A) tail by
a variety of deadenylases, leading to the removal of the
50 cap by a decapping enzyme and the 50–30 exonucleolytic
degradation of the mRNA (5,8). Several deadenylases
have been identiﬁed in eukaryotes (4,9). Among them,
poly(A)-speciﬁc ribonuclease (PARN) is a key enzyme
involved in the deadenylation of mRNA in a cap-
dependent manner (10–14).
PARN is localized in both the nucleus and cytoplasm in
higher eukaryotic cells (12,15). During the meiotic matura-
tion of Xenopus oocytes, PARN participates in the trans-
lational silencing of maternal mRNAs (12,16). PARN
was recently reported to be a component of the cytoplas-
mic polyadenylation element binding protein-containing
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in early embryonic development (17). In the CPEB-
containing complex, PARN interacts with the poly(A)
polymerase Gld2, inhibits the polyadenylation activity
and shortens the poly(A) tail, thus accomplishing transla-
tional silencing (17). When the oocytes are induced to
mature with progesterone, Aurora A phosphorylates the
CPEB-containing complex to expel PARN, resulting in
Gld2-catalyzed default polyadenylation and subsequent
translation initiation (17).
PARN is a divalent metal ion-dependent 30 exonuclease
(10,13,14,18) that speciﬁcally catalyzes the 30–50 degrada-
tion of the single-stranded poly(A) tail of mRNA with a
free 30-hydroxyl group (10,11,13). In addition, PARN
interacts with the m
7GpppG cap (19,20), which enhances
its deadenylation activity (14,19–21). A sequence align-
ment revealed that PARN contains a region homologous
to the DEDDh family of 30–50 exonucleases (22), which is
interrupted by a long insertion with an R3H domain
(23,24). On the other hand, the C-terminal truncated
human PARN (23) did not bind to the mRNA cap,
suggesting that the putative cap-binding domain resides
in the C-terminal region. Thus, PARN contains three
domains: the nuclease domain, the R3H domain and the
putative cap-binding domain. Recent crystallographic and
mutagenesis studies of human PARN revealed that the
C-terminal truncated PARN forms a homodimer through
its nuclease domain, and that the nuclease domain of
each subunit binds to adenosine nucleotides (23). This
dimer formation by PARN may be essential for its
poly(A)-speciﬁc activity. However, the crystal structure
lacked structural information on the putative cap-binding
domain. As shown in Figure 1, an examination of the
amino acid sequences among the PARNs from several
species revealed that the cap-binding domain contains
sequences homologous to the characteristic RNP1 and
RNP2 sequences of the RNA recognition motif (RRM)
(16), which are generally responsible for the nucleotide
binding activity. Considering the importance of the
m
7GpppG cap for PARN activity, the cap recognition
mechanism should be elucidated.
In this study, we determined the solution structures of
the free and cap-bound forms of the cap-binding domain
of mouse PARN by heteronuclear NMR experiments. The
3D structure of the PARN cap-binding domain includes
an RRM as predicted by the amino acid sequence analysis.
In addition, we performed binding assays with RRM and
the m
7GpppG cap analog, which identiﬁed the important
sites for the cap binding. The present results revealed the
novel cap-binding mode of PARN RRM, which is unique
among the structurally and functionally well-studied
RRM family members.
MATERIALS AND METHODS
Cloning
The DNA fragment encoding the cap-binding domain of
PARN (residues 430–516) was ampliﬁed from the RIKEN
FANTOM mouse cDNA clone with the ID 1200003I18
(25), by conventional polymerase chain reaction (PCR),
and was subcloned into pCR2.1 (Invitrogen, Carlsbad,
CA, USA). The cap-binding domain was expressed with
an extra His6-tail, a TEV protease cleavage site, a (Gly–
Gly–Ser)2–Gly sequence at the N-terminus and a Ser–
Gly–Pro–Ser–Ser–Gly sequence at the C-terminus.
Several deletion mutants of PARN that contained the
cap-binding domain and its N- and/or C-terminal ﬂanking
regions, encoding residues 420–506, 420–516, 420–536,
430–506, 430–516 and 430–536, were ampliﬁed by PCR
and subcloned into pET15b (Merc, San Diego, CA,
USA). Selected point mutations (K447A, K450A,
W468L and D471A) were introduced into the cap-binding
domain (residues 430–516), using a QuikChange site-
directed mutagenesis kit (Stratagene, La Jolla, CA, USA).
Expression and purification
The unlabeled and the
15N,
13C-labeled PARN cap-
binding domains used for NMR experiments were synthe-
sized by the cell-free protein expression system (26). After
the reaction, each protein was isolated by chromatography
on a Ni
2+ aﬃnity column, and the His6-tag was removed
by proteolysis. Subsequent cation-exchange chromatog-
raphy (HiTrap SP, GE Healthcare, Buckinghamshire,
England) yielded the highly puriﬁed cap-binding
domain. In order to prepare the NMR samples, the pro-
tein was transferred into 20mM sodium phosphate buﬀer
(pH6.0), 100mM NaCl, 1mM 1,4-DL-dithiothreitol-d10
(d-DTT) and 0.02% sodium azide, prepared with either
1H2O/
2H2O (9:1) for the
15N,
13C-labeled cap-binding
domain or
2H2O for the unlabeled cap-binding domain,
by ultraﬁltration using a Centricon YM3 ﬁlter device
(Millipore, Billerica, MA, USA). The protein concentra-
tion was increased simultaneously to 0.4–1.0mM.
The wild-type and mutant forms of the cap-binding
domain of PARN were overexpressed in Escherichia
coli BL21(DE3) cells (Merc, San Diego, CA, USA) for
pull-down assays. The cells were grown in 2  YT
medium at 378Ct oa nO D 600=0.6, and were induced
with 0.1mM isopropyl-b-D-thiogalactopyranoside
(IPTG) at 208C. Cells were harvested after  16h by cen-
trifugation, suspended in 20mM Tris–HCl buﬀer (pH 7.5)
containing 1M NaCl, 30mM imidazole, 1mM 1,4-DL-
dithiothreitol (DTT), 0.1mg/ml lysozyme, DNaseI and
protease inhibitor cocktail (Nacalai Tesque, Kyoto,
Japan), and lysed with a sonicator. Cell debris and inclu-
sion bodies were removed by centrifugation. The super-
natant was loaded on a Ni
2+-NTA-agarose column
(Qiagen, Inc., Hilden, Germany), which was then
washed thoroughly with 20mM Tris–HCl buﬀer (pH
7.5), 1M NaCl, 30mM imidazole and 1mM DTT. The
proteins were eluted with 20mM Tris–HCl (pH 7.5), 1M
NaCl and 200mM imidazole.
The cap analogs (m
7GpppG, GpppG and GpppA) and
the 10-mer poly(A) oligonucleotide (A10) were purchased
from New England Biolabs (Ipswich, MA, USA) and
Dharmacon Research, Inc. (Lafayette, CO, USA) respec-
tively.Complexeswerepreparedbytheadditionofaliquots
of the lyophilized cap analog to the protein NMR samples.
NMRspectroscopy
All NMR spectra of the uniformly
15N,
13C-labeled cap-
binding domain in its free form were acquired on Bruker
Nucleic Acids Research, 2008, Vol. 36, No. 14 4755AVANCE 600 and AVANCE 800 spectrometers at a
probe temperature of 258C. Backbone and side chain
1H,
15N and
13C resonances of the free protein were assigned by
standard double and triple resonance NMR experiments
(27–30). Sequence-speciﬁc backbone assignments were
achieved by two-dimensional (2D)
1H–
15N heteronuclear
single quantum correlation (HSQC) and 3D HNCO,
HN(CA)CO, CBCA(CO)NH and HNCACB spectra.
Assignments of side chain resonances for nonaromatic
residues were obtained from 2D
1H-
13C HSQC and 3D
HBHA(CO)NH, HC(CCO)NH, C(CCO)NH, H(C)CH-
correlation spectroscopy (COSY), H(C)CH-total corre-
lated spectroscopy (TOCSY) and (H)CCH-TOCSY,
whereas assignments for aromatic residues were performed
by H(C)CH-correlation spectroscopy (COSY), aided by
3D
15N- and
13C-separated nuclear Overhauser eﬀect spec-
troscopy (NOESY)–HSQC spectra, which were recorded
with mixing times of 80ms.
Spectra for the cap-bound state were acquired using an
NMR sample containing  0.5mM
15N,
13C-labeled cap-
binding domain and  2.5mM unlabeled cap analog, in
90% H2O, 10%
2H2O.
1H,
15N and
13C resonance assign-
ments of the cap-binding domain in complex with the cap
were achieved by comparison of the 3D
15N- and
13C-separated NOESY–HSQC spectra between the free
and cap-bound states. For the resonance assignment of
the m
7GpppG cap analog,
1H–
13C heteronuclear multiple
quantum coherence (HMQC) for the detection of the
naturally abundant
13C resonances, 2D homonuclear
TOCSY and 2D homonuclear NOESY experiments
were performed under the same conditions as in the ﬁnal
stage of the titration experiment (see subsequently).
Intermolecular NOEs involving the protons of the cap-
binding domain and the cap analog in the complex were
obtained from 3D
15N-separated NOESY–HSQC (80, 100
and 200ms mixing times at 258C) and 3D
13C-separated
NOESY–HSQC (80, 100 and 200ms at 258C; 150ms at 15
and 258C) spectra. In order to distinguish between the
intra- and inter-molecular NOEs, 2D [F1, F2]
13C-ﬁltered
NOESY, 2D [F2]
13C-ﬁltered NOESY (31) (150 and
300ms at 5 and 158C) and 3D [F1]
13C-ﬁltered [F3]
13C-edited NOESY–HSQC (32) (300ms at 15 and 258C)
spectra were measured. All NMR data for the structure
calculations were processed using the NMRpipe soft-
ware (33) and were analyzed with KUJIRA, a program
suite for interactive NMR analysis (34), used in conjuga-
tion with NMRView (35).
Structure calculations
The 3D structures of the cap-binding domain in its free
and complex forms were determined with the program
CYANA (36–38), which implements automated NOE
assignments and structure calculations with torsion angle
dynamics steps. Peak lists containing the chemical shifts
and the peak volumes of NOEs within the protein were
used to obtain lists of intramolecular protein distance
restraints. These generated lists were reviewed and com-
bined with a list containing manually assigned NOE dis-
tances obtained by resolving ambiguities, such as spectral
overlap. In the case of the complex, the lists containing
manually assigned intramolecular NOEs within the cap
analog and inter-molecular NOEs between the cap and
the protein were further added as distance restraints.
Secondary structure elements were veriﬁed by the NOE
patterns: Hai–HNi+3 and Hai–Hbi+3 for the a-helical
structure, and HNi–HNj,H N i–Haj+1 and Hai-1–Haj+1
for the antiparallel b-sheet. Protein backbone f, c and
side chain  1,  2 torsion angle restraints were determined
by a chemical shift database analysis, using the program
TALOS (39), and by inspecting the pattern of intraresid-
ual NOE intensities (40), respectively. Hydrogen bonding
restraints for the backbone atoms (rNH–O=1.7–2.2A ˚ ,
rN–O=2.6–3.3A ˚ , rNH–C0 =2.6–3.5A ˚ , rN–C0 =3.6–4.6A ˚ )
were also introduced within the secondary structures
during the ﬁnal stage of reﬁnement. Furthermore, stereo-
speciﬁc assignments for the isopropyl methyl and methy-
lene groups were determined with CYANA, by the
GLOMSA method (41). The conﬁguration around the
glycosidic bond and the sugar puckering of the nucleotide
moieties in the cap analog were estimated, based on the
intensities of the H8–H20 and H8–H30 NOE cross-peaks in
the 2D NOESY spectra (42,43). Starting from 100 ran-
domized conformers, ﬁnal ensembles of 20 and 40 confor-
mers were selected on the basis of the lowest ﬁnal CYANA
target function values for the cap-free and cap-bound
forms, respectively. For the cap-binding domain in the
cap-bound form, the selected 40 conformers were subse-
quently energy-minimized, using the SANDER module of
AMBER9 (http://amber.scripps.edu) with the generalized
Born solvent model (44), and the 20 conformers with the
lowest energy were selected for further structure analysis.
The qualities of the structures were analyzed using the
programs MOLMOL (45) and PROCHECK–NMR (46).
The buried residues were deﬁned as those with a relative
solvent accessibility of <20%, calculated by GETAREA
(http://pauli.utmb.edu/getarea). The coordinates for the
ensembles of the 20 conformers of the cap-binding
domain in its free and cap-bound forms were deposited
in the RCSB Protein Data Bank, under the accession
codes 1WHV and 2ROK, respectively.
Pull-down assays withthe capanalog
The wild-type and mutant proteins of the cap-binding
domain were incubated with m
7G(50)ppp-Sepharose 4B
beads (GE Healthcare; Buckinghamshire, England), in a
buﬀer containing 20mM bis-Tris, pH 5.5, 100mM NaCl,
1mM DTT and 1mM EDTA, for 1h at 48C. The beads
were washed with the same buﬀer, and the bound proteins
were eluted by adding 2  SDS gel loading buﬀer and
boiling for 5min. After centrifugation, the supernatant
was collected and the proteins were fractionated by 15–
25% SDS–PAGE and visualized by staining with
Coomassie brilliant blue.
NMR titration experiments
NMR titration experiments of the cap-binding domain
with the cap analog, m
7GpppG, were performed byrecord-
ing 2D homonuclear TOCSY (mixing time of 45ms) and
2D homonuclear NOESY (80, 150 and 300ms) spectra
in
2H2O at 5, 15 and 258C. Increasing amounts of the
4756 Nucleic Acids Research, 2008, Vol. 36, No. 14unlabeled m
7GpppG cap analog were added to 0.4mM
unlabeled cap-binding domain, to achieve molar ratios of
1:0, 1:0.25, 1:0.5, 1:0.75, 1:1, 1:1.25, 1:1.5, 1:5 and 1:12.
Titration experiments for
1H–
15N resonances were also
performed using the
15N,
13C-labeled cap-binding domain
with three diﬀerent cap analogs, m
7GpppG, GpppG and
GpppA. Two-dimensional heteronuclear
1H–
15N HSQC
spectra were measured to monitor the titrations. The
molar ratios of protein:m
7GpppG were 1:0, 1:1 and 1:5;
those of protein:GpppG were 1:0, 1:0.1, 1:0.4, 1:0.7, 1:1,
1:1.2, 1:1.4, 1:1.7, 1:2, 1:2.4, 1:3, 1:3.3, 1:3.9 and 1:4.8;
and those of protein:GpppA were 1:0 and 1:4.8. These
2D spectra were processed with the XWINNMR (Bruker,
Rheinstetten, Germany) and NMRpipe software (33), and
were analyzed with Sparky (47). Curve ﬁtting for the deter-
mination of the dissociation constant (Kd) was achieved by
using the software IGOR Pro (WaveMetrics, Inc., Lake
Oswego, OR, USA).
For titration experiments of the cap-binding domain
with a 10-mer poly(A) oligonucleotide, A10, the 2D
1H–
15N HSQC spectra were acquired at 258C with
15N,
13C-labeled cap-binding domain in a 90% H2O/10% D2O
solution, containing 20mM sodium phosphate buﬀer, pH
6.4, 100mM NaCl and 1mM d-DTT. Titrations were
carried out using 0.2mM cap-binding domain and various
concentrations of unlabeled A10 to achieve a series of dif-
ferent cap-binding domain:A10 molar ratios (1:0, 1:0.1,
1:0.2, 1:0.8, 1:1 and 1:3).
Relaxation measurements
To determine the
15N relaxation rates (R1 and R2) and
the steady-state
1H–
15N NOE values of the cap-binding
domain with and without the cap analog, enhanced-
sensitivity experiments were performed using the standard
method (48) on a Bruker AVANCE-600 spectrometer
equipped with and without a cryoprobe at 258C. R1 and
R2 experiments were measured with relaxation delays of 5,
65, 145, 246, 366, 527, 757 and 1148ms for R1, and 32, 48,
64, 80, 96, 112, 128 and 144ms for R2. Duplicate spectra
were recorded for delays of 5, 145, 366 and 757ms (R1),
and 32, 64, 96 and 128ms (R2), to estimate the uncertain-
ties of the peak heights. A recycle delay of 1s was used for
the measurement of the R1 and R2 data. For the steady-
state
1H–
15N NOE measurement, a relaxation delay of 3s
and a
1H presaturation time of 3s were used in the NOE
experiment, and a 6s relaxation delay was used in the
reference experiment. NMR peak heights determined by
Sparky were used for the program ‘sparky2rate’ (http://
xbeams.chem.yale.edu/ loria/software.htm). The R1 and
R2 values were obtained by ﬁtting the intensities of
the peak heights as a function of the relaxation delay
to a two-parameter, single exponential curve, using the
nonlinear least-squares ﬁtting program, CURVEFIT
(A.G. Palmer, Columbia University). The uncertainties
of the R1 and R2 values were estimated by means of
Monte-Carlo simulations in the CURVEFIT program,
based on the peak intensities from duplicated experiments.
The steady-state NOE values were obtained from the
ratio of the peak intensities in experiments with and with-
out
1H saturation. Errors in NOE values were estimated
using the root-mean-square of the background noise of
each spectrum (48).
Isothermal titration calorimetry measurements
PARN RRM and the cap analogs (m
7GpppG, GpppG
and GpppA) were all dissolved in 20mM sodium phos-
phate buﬀer (pH 6.0), 100mM NaCl and were thoroughly
degassed before use. The concentration of PARN RRM in
the sample cell was 30mM, and that of each cap analog
was 375mM.
Isothermal titration calorimetry (ITC) measurements
were performed with a Microcal (Amherst, MA, USA)
VP–ITC calorimeter. Measurements were made by titra-
tion of the cap analogs into the PARN RRM at a tempera-
ture of 258C. For titration experiments, PARN RRM was
placed in a 1.4ml reaction cell. The m
7GpppG, GpppG
and GpppA were each loaded in the 250ml injection
syringe, and a series of 5ml injections were made over
16s, with a spacing of 180s between injections over
120min. The reference power was set to 20mcal/s, and
the stirring speed was 300r.p.m. Parallel control experi-
ments, to correct the heat of mixing, were performed by
adding the cap analog to a sample cell containing only
buﬀer, without PARN RRM. The heat generated due to
dilution of the titrants was very small and was ignored for
the analysis. The thermodynamic data were processed with
the Microcal ORIGIN program to extract the enthalpic,
entropic and equilibrium constants. Nonlinear least-
squares ﬁtting was done using a single site binding model.
RESULTS
Stable andfunctional cap-binding domain ofPARN
forstructure determination
An amino acid sequence analysis predicted that PARN
possesses the putative RNP1 and RNP2 sequences, which
led us to assume that the region spanning residues 430–506
(numbering based on mouse PARN) adopts the RRM
fold. On the basis of the domain boundary prediction,
we designed six protein fragments and produced them by
bacterial overexpression: residues 420–506, 420–516,
420–536, 430–506, 430–516 and 430–536 (Figure 1). Each
fragment was puriﬁed using Ni
2+ aﬃnity chromatography
(see Materials and methods section). The fragments span-
ning residues 420–506 and 430–506, which lacked the
C-terminal regions, formed inclusion bodies (data not
shown).
To select the active fragment for the cap analog, we
conducted pull-down assays with the 420–516, 420–536,
430–516 and 430–536 fragments. The four fragments
were incubated with m
7G(50)ppp-Sepharose, and the
bound proteins were separated by SDS–PAGE
(Figure 1C). The protein bands on the gel revealed that
all of these fragments possessed binding activity for the
cap analog. Therefore, the shortest fragment, spanning
residues 430–516, was selected for structural studies of
PARN.
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Unlabeled or
15N,
13C-labeled proteins corresponding to
the cap-bindingdomain were synthesized byacell-free pro-
tein expression system (26), and the proteins were puriﬁed
by Ni
2+-aﬃnity and cation-exchange chromatography.
The NMR experiments for the structure determination of
the cap-binding domain were performed using standard
techniques (27–29), as described in the Materials and meth-
ods section. Secondary structure elements were identiﬁed
by the patterns of the characteristic backbone NOE con-
nectivities and by the program TALOS (39) (see Materials
and methods section). The solution structure was calcu-
lated using the CYANA program, based on 1266 NOE-
derived inter-proton distance restraints, 14 hydrogen
bonds and 143 dihedral angle restraints for the ﬁnal calcu-
lation. Experimental restraints and structural statistics for
the 20 lowest energy structures are summarized in Table 1,
indicating that residues 440–509 adopted a well-deﬁned
structure, with an RMS deviation of 0.33A ˚ for the back-
bone atoms.
The structure of the cap-binding domain of PARN
is composed of four b-strands, b1 (V440–T444), b2
(Q465–W468), b3 (S473–S477) and b4 (R498–T501), and
three a-helices, aA (T451–F458), aB (P481–S491) and aC
(Y502–K509). It forms a babbaba fold, with the ﬁrst and
second a-helices packed against one four-stranded anti-
parallel b-sheet (Figure 2A). This 3D structure conﬁrmed
that the cap-binding domain of PARN contains the RRM
fold (the babbab topology). In addition to the RRM fold,
the cap-binding domain possesses an extra a-helical struc-
ture at its C-terminus (aC, residues 502–509), which we
named PARN RRM. The canonical RRM has well-con-
served consensus sequences, termed RNP1 and RNP2,
which correspond to the b3- and b1-strands, respectively.
Both RNP1 and RNP2 include aromatic residues with
solvent-exposed side chains that participate in the RNA
interaction (49–52). In the case of PARN RRM, however,
the aC-helix lies on the RNA recognition surface and
covers the b1-strand (Figure 2A). In particular, an aro-
matic residue within the aC-helix (Y505) is stacked with
H442 in RNP2 by a  –  stacking interaction, and Y502at
the N-terminus of the aC-helix participates in a cation– 
interaction with R437 from the N-terminal extension of
PARN RRM (Figure 2A). Moreover, aliphatic residues
[V440 (b1) and V506 (aC)] and aromatic residues [H442
(RNP2), F475 (RNP1), Y502 (aC) and Y505 (aC)] are
involved in the hydrophobic interaction between the
b-sheet surface and the additional aC-helix, resulting in
the formation of the hydrophobic core by the residues
on RNP1, RNP2 and the aC-helix (red circles in
Figures 1A and 2A). Consequently, the aromatic rings
on RNP1 and RNP2, which potentially contribute to the
RNA interactions in the case of the canonical RRMs, are
completely buried in the hydrophobic core, in the case of
PARN RRM. On the other hand, one of the tryptophan
residues, W468, which is conserved among the PARNs
from several species, is located on the b2-strand. The
bulky side chain of this residue is exposed to the solvent
(Figure 2A). In addition, the region in the vicinity of
W468 is partly stabilized by (i) the side chain of I469,
which is not fully buried in the aforementioned hydropho-
bic core, but interacts with the aromatic rings of its central
residues, F475, H442 and Y505; and (ii) a tight turn con-
necting b2 and b3, which comprises residues D470–S473.
These two structural components, as well as the loop
connecting b1 and aA, form the rim of a shallow basin.
The indole ring of W468 resides on the bottom of the
basin.
RNP2 RNP1
440 450 460 470
  mouse 430 F GPDLQPKRDHVLHVT PKEWKTSDLYQLFSAFGNIQISWIDDTSAFVSLSQPEQVQIAVNTSKYAESYRIQTYAEYVGKKQKGKQVK 516
  human 437 GPDLQPKRDHVLHVTFPKEWKTSDLYQLFSAFGNIQISWIDDTSAFVSLSQPEQVKIAVNTSKYAESYRIQTYAEYMGRKQEEKQIK 523
  zebrafish 435 GPDLQPKRDHVLYVTFPKEWKTSDLYQLFSAFGNIQVSWVDDTSAFVSLSQTEQVQIAMNTSRYAESYRIQTYAEYLQSRQKNTHSS 521
  honey bee 420 GDDPNPSRDHVFHLTFPKEWKFNDISHLFSPFGSVHVSWLSDISAYIELHRRDQVNEVMKVLAKTSTYKLQRYADYQASLENFNTGE 506
480 490 500 510
PARN R3H
Exoribonuclease domain
100 200 300 400 500 600
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Figure 1. (A) Amino acid sequence alignment of the cap-binding domains of PARNs from diﬀerent species. The positions of secondary structure
elements, as observed in the mouse cap-binding domain, are shown at the top of the alignment. The residues involved in hydrophobic core formation,
as determined by GETAREA, are indicated by red circles (V440, H442, F475, Y502, Y505 and V506) and black boxes. Completely and partially
buried residues are shown by ﬁlled and half-ﬁlled symbols, respectively. Residues with obvious chemical shift changes (above the mean value + 1
SD) upon cap binding are boxed. Residues directly involved in cap binding are highlighted in gray. The highly conserved ‘RNP1’ and ‘RNP2’
sequences among the canonical RRMs (52) are aligned with the sequences in the cap-binding domain of PARN and are indicated below the
sequences. Positions of amino acid substitutions (see text) are denoted by black triangles. (B) Domain structure of PARN and deletion constructs
containing the cap-binding domain of PARN with N- and C-terminal ﬂanking sequences of varying lengths. The RRM region was predicted by the
secondary structure elements and is shaded dark gray. Plus and minus signs indicate constructs that yielded soluble protein or inclusion bodies,
respectively. The arrow identiﬁes the construct that was selected for the solution structure studies. (C) Pull-down assay of the cap-binding domain
with m
7G(50)ppp-Sepharose.
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the capanalog
PARN reportedly interacts with the cap analog as
well as the poly(A) tail (14,19–21). Our pull-down
assays (Figure 1C) demonstrated that PARN RRM (resi-
dues 430–516 of mouse PARN) itself can interact with the
cap analog. In order to identify the cap-binding sites and
to investigate whether poly(A) interacts with PARN
RRM, NMR titration experiments of PARN RRM were
performed using the unlabeled cap analogs (m
7GpppG,
GpppG and GpppA), and the 10-mer unlabeled poly(A)
oligonucleotide (A10). The
1H–
15N HSQC spectra of
PARN RRM with A10, at molar ratios of 1:0–1:3, revealed
that none of the
1H–
15N resonances were aﬀected by the
addition of A10 (Supplementary Figure S1). This result
indicates that A10 does not interact with the PARN
RRM fragment, spanning residues 430–516. On the
other hand, the
1H–
15N HSQC spectra of PARN RRM
alone and in the presence of each cap analog at a 1:5 molar
ratio revealed that some resonances were shifted by the
addition of the cap analogs. The resonances of the
PARN RRM residues F445, K450, T451, I469 and
D470 underwent large chemical shift changes in the pre-
sence of m
7GpppG (Figure 2B). The resonances of the
same residues showed some chemical shift changes in
the presence of GpppG and GpppA as well. However,
the magnitudes of their chemical shift changes were
much smaller than those for m
7GpppG (Supplementary
Figure S2). For example, the largest id value
(¼½ ð  dHNÞ
2 þð  dN=6:5Þ
2 
1=2) was 0.59p.p.m. for T451
in the presence of m
7GpppG, while the values were
0.064 and 0.095p.p.m. in the presence of GpppG and
GpppA, respectively. Even after m
7GpppG was added
to the solution containing PARN RRM and m
7GpppG
at a molar ratio of 1:1, to make a ratio of 1:5 in the course
of the titration, no further shifting of the resonances of
PARN RRM residues was observed. This result indicates
that the m
7GpppG-bound form of PARN RRM almost
completely predominates over the free form after the addi-
tion of an equimolar amount of m
7GpppG. This was not
the case for the GpppG and GpppA titrations. In the
latter cases, further shifting was observed upon increasing
the protein:cap analog ratio to 1:5, and more shifting was
likely to occur by further addition of the cap analogs.
These observations are consistent with the thermodynamic
parameters acquired by ITC, where we obtained a Kd
value of  45mM for the interaction between PARN
RRM and m
7GpppG. However, the Kd values for the
interaction between PARN RRM and either GpppG or
GpppA could not be determined under the same experi-
mental conditions, probably due to the 10- to several 100-
fold weaker Kd values (Supplementary Figure S3).
Therefore, we concluded that the fragment spanning resi-
dues 430–516 indeed engages the cap analog, as identiﬁed
by the pull-down assay (Figure 1C), and that the interac-
tion is highly speciﬁc to the N
7-methylated cap analog. In
addition, our results also indicated that A10 could not bind
to the cap-binding site on PARN RRM.
Table 1. Structure statistics of free PARN RRM and the RRM:cap analog complex
Free PARN RRM RRM:cap complex
Restraints for ﬁnal structure calculations
Number of NOE distance restraints 1266 1131
Intraresidue 372 348
Sequential (|i j|=1) 367 298
Medium–range (1 < |i j| < 5) 178 154
Long–range (|i j| 5) 349 314
Protein–RNA intermolecular NA 17
Number of dihedral angle restraints
a
f angles 61 42
c angles 58 41
  angles 24 27
Number of hydrogen bond restraints
b 14 18
Structure statistics (20 structures)
Mean number of NOE violations >0.2A ˚ 00
Mean number of dihedral angle violations >58 0 1.7 1.5
Average CYANA target function (A ˚ 2) 0.01 0.08
Average AMBER energy (kcal mol
 1)N A  4785 8
RMS deviation to mean coordinates
c
Backbone heavy atoms (A ˚ ) 0.33 0.07 0.52 0.11
All heavy atoms (A ˚ ) 0.74 0.07 0.93 0.14
Ramachandran plot analysis
d
Residues in most favored regions (%) 89.2 89.2
Residues in additionally allowed regions (%) 10.8 10.5
Residues in generously allowed regions (%) 0.0 0.3
Residues in disallowed regions (%) 0.0 0.0
af and c angles were derived from the program TALOS. The   angles contain 18  1 and 6  2 angle restraints for free
PARN RRM and 19  1 and 8  2 angle restraints for the RRM:cap complex.
bOnly hydrogen bonds supported by NOEs were used.
cResidues 440–509 for free PARN RRM. Residues 440–509 and m
7GpppG for the RRM:cap complex.
dFrom PROCHECK-NMR (46) for 20 structures. Residues 440–509 were used.
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complex were achieved by comparing the 3D
15N- and
13C-edited NOESY–HSQC spectra of free and cap-
bound PARN RRM. The chemical shift changes in the
backbone amide nitrogens and protons between the free
and bound forms of PARN RRM were plotted versus the
residue number (Figure 2C). Mapping of these shifted
residues on the surface of PARN RRM revealed that
signiﬁcant chemical shift changes were observed for the
residues in the loop between b1 and aA, and at the
C-terminus of b2, which surround the tryptophan residue
W468 in the tertiary structure (Figure 2D). This suggests
that, as compared with the canonical RRMs, PARN
RRM uses a distinct binding surface for the RRM–
nucleotide interface. The dissociation constant, Kd,
was calculated using the average of the estimated values
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Figure 2. 3D structure of mouse PARN RRM and titration experiments of PARN RRM with the cap analog. (A) (Left) Ribbon representation of
PARN RRM (residues 436–512). The secondary structure elements are labeled and colored green, orange and red for b-strands, aA and aB, and aC,
respectively. (Right) Superposition of the 20 conformers with the lowest CYANA target function of PARN RRM (residues 436–512). Aromatic side
chains and residues discussed in the text are labeled and colored blue and yellow, respectively. This structure is rotated by 608 around the y-axis in
the left panel. (B)
1H–
15N HSQC spectra of PARN RRM alone (black) and in the presence of the cap analog at a molar ratio of 1:5 (red).
Resonances that shifted signiﬁcantly are labeled with the residue number and the one-letter amino acid code. (C) Chemical shift changes of PARN
RRM upon cap binding. The chemical shift change, id, was determined as d ¼½ ð  dHNÞ
2 þð   N=6:5Þ
2 
1=2 (70), where idHN and idN are the
chemical shift diﬀerences for HN and
15N, respectively. The mean value and the mean value + 1 SD are shown by continuous and dashed lines,
respectively. (D) Mapping of residues with signiﬁcant chemical shift changes upon cap binding on the PARN RRM structure, which is viewed from
the same direction as in A, right panel. Residues with above-average chemical shift changes are colored yellow, and residues with chemical shift
changes above the mean value +1 SD are colored orange. The aromatic side chain of W468 is colored green (see also Figure 3).
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1H resonances of the representative
residues I466 and W468. The Kd value for cap analog
binding by PARN RRM was approximately 20mM with
a stoichiometry of 1:1, which is roughly equivalent to the
previously reported value (53).
We next focused on aromatic residues, and carried out
further NMR titration experiments to monitor the chemi-
cal shift changes in the side chain resonances. The 2D
TOCSY spectra of the free and cap-bound forms of
PARN RRM revealed that the resonances originating
from W468 undergo the largest changes upon cap binding
among the aromatic residues of PARN RRM
(Supplementary Figure S4). The chemical shifts of the
aromatic residues F445 and Y455 were also aﬀected by
the addition of the cap analog (Figure 3). These residues
are located in the vicinity of W468 in PARN RRM, sug-
gesting that W468 of PARN RRM directly participates in
the recognition of the m
7GpppG cap analog. In contrast,
the aromatic residues within the b-sheet surface (F475)
and those on the aC-helix (Y502 and Y505), as well as
the other conserved tryptophan residue, W449, were scar-
cely shifted (black bars in Figure 3). As a consequence,
PARN RRM uses the exposed tryptophan residue (W468)
for the cap recognition, and the recognition is not
mediated by the b-sheet surface of the canonical RRMs.
Overall structure of thePARN RRM–cap complex
To solve the complex structure of PARN RRM with
the m
7GpppG cap analog, the resonances of the cap
analog were assigned, using 2D
1H–
13C HMQC, 2D
TOCSY and 2D NOESY experiments. Cross peaks
between the N
7-methyl guanosine (m
7G) moiety and
the second guanine were observed in the NOESY
spectrum (Supplementary Figure S5). Subsequently,
several 2D and 3D NOESY-type experiments were per-
formed, to assign the inter- and intra-molecular NOEs
(see Materials and methods section). The structure of
the PARN RRM in complex with the cap analog (here-
after referred to as the RRM:cap complex) was calculated,
using the programs CYANA (36–38) and AMBER9
(http://amber.scripps.edu). Structural statistics for the
20 lowest energy structures are summarized in Table 1.
The overall structure of PARN RRM in the cap-bound
form turned out to be the same as that of the cap-free
form, especially in the region spanning residues 438–507
(Figures 2A and 4A). Consistent with the results of
our NMR titration experiments, intermolecular NOEs
between the m
7G moiety of the cap analog and
several amino acid residues of PARN RRM (W468,
D470 and D471) were observed in the NOESY spectra
(Supplementary Figure S6). The structure of the
RRM:cap complex was determined from a total of 1241
NMR-derived restraints, including 1114 intramolecular
NOEs, 17 inter-molecular NOEs and 110 dihedral angle
restraints (Figure 4B and Table 1). The RRM:cap com-
plex structure revealed that the interaction of PARN
RRM with the cap analog is achieved mainly by  – 
stacking interactions between the aromatic side chain of
W468 of PARN RRM and the m
7G base of the cap
analog. In addition, intramolecular base-stacking interac-
tions between the m
7G and second guanosine bases seem
to be present in the complex structure. The aromatic
ring of W468, the base of m
7G and that of the second
guanosine were aligned nearly parallel to each other. In
other words, the m
7G base was sandwiched between the
aromatic ring of W468 on the bottom and the second
guanosine base on the top (Figure 4B). The structure of
the RRM:cap complex also indicated possible hydrogen
bonding interactions between the amino acid residues of
PARN RRM in the vicinity of W468 and the bases of the
cap analog (Figure 4C): the backbone carbonyl oxygen
atoms of K447, W449 and D471 formed NH...O=C
hydrogen bonds with N2, N1 and N2 of the m
7G base,
respectively. Therefore, the 3D architecture of the back-
bone atoms of these residues is also important for the
cap-binding activity of PARN RRM.
NMRdynamics studies
To investigate the local mobility of PARN RRM includ-
ing the aC-helix, in the presence and absence of the cap
analog, 2D
1H–
15N NMR relaxation experiments were
performed using a Bruker 600MHz spectrometer at a
probe temperature of 258C. The
15N R1 and
15N R2
NMR relaxation rates and the steady-state
1H–
15N NOE
values for the backbone amides of PARN RRM in its free
and complex forms were determined, and are plotted in
Figure 4D. Overlapped resonances and those with very
poor signal-to-noise ratios were excluded from the relaxa-
tion analysis. The average values of the
15N R1 and
15N R2
relaxation rates and the steady-state
1H–
15N NOEs were
calculated for residues 440–509, excluding the N- and
C-terminal ﬂexible regions. The average
15N R1 value
was 1.7s
–1 for free PARN RRM. Upon the formation
of the RRM:cap complex, the value decreased slightly to
1.5s
–1, as expected from the slight increase in the molecu-
lar mass, from 11 to 12kDa. The
15N R2 values were
similar for most of the residues in the free and complex
forms (13s
 1) except for T451, which will be described
subsequently. The average steady-state
1H–
15N NOE
values were 0.72 and 0.75 for free PARN RRM and the
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Figure 3. NMR titration experiments focused on the resonances of
aromatic side chains in PARN RRM at 258C. The chemical shift
changes, id, were obtained by calculating the absolute diﬀerence of
the
1H chemical shifts in the absence and presence of an excess of the
cap analog. Resonances of aromatic side chains with chemical shift
changes above the mean value (continuous line) are colored cyan,
and those with chemical shift changes above the mean value +1 SD
(dashed line) are colored green.
Nucleic Acids Research, 2008, Vol. 36, No. 14 4761RRM:cap complex, respectively. The
15N R1 and
15N R2
relaxation rates and the steady-state
1H–
15N NOE values
of the aC-helix are similar to those of other secondary
structure elements in PARN RRM (Figure 4D).
Therefore, the entire PARN RRM including the
aC-helix (residues 440–509) is stable and well-structured
in solution, regardless of the presence of the cap analog.
ConcerningtheNMRrelaxationratesfortheaminoacid
residues located in the proximity of W468, several diﬀer-
enceswereobservedbetweenthefreeandcap-boundforms.
Namely, the
15N R1 and
15N R2 relaxation rates for T451,
which is located at the N-terminus of the aA-helix, were
higher than the respective average values in the free form
(Figure 4D). This indicates internal motions on the micro-
to milli-second time scale for T451 in the free form. In the
presence of the cap analog, however, the
15N R1and
15N R2
relaxation rates for T451 were comparable to the average
values, suggesting the suppression of internal motions. The
1H–
15N resonances originating from residues D470, D471
andS473, which reside within the b2–b3turn andgather on
one side of W468 (Figure 4B), were severely overlapped
with other resonances in the case of free PARN RRM.
Thus, it was diﬃcult to compare the parameters of the
individual dynamics for these residues between the free
and cap-bound forms. Inter- and intra-residue NOE con-
nectivities originating from these residues could hardly be
detected in the
15N-separated NOESY–HSQC spectrum of
the free form. In contrast, in the case of the RRM:cap
complex, these resonances were clearly separated in the
1H–
15N HSQC spectra, and many inter- and intra-residue
NOE connectivities were observed for these residues.
Taken together, the NMR relaxation experiments and
the NOE connectivities strongly suggest that the structure
of the residues within the b2–b3 turn as well as at the
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Figure 4. Structure of the PARN RRM:cap complex and NMR dynamics studies for PARN RRM in the presence and absence of the m
7GpppG cap
analog. (A) Stereo view illustrating a trace of the backbone atoms for the ensemble of the 20 structures of the PARN RRM:cap complex (residues
436–512). Residues in b-strands, aA and aB and aC are colored green, orange and red, respectively. The aromatic side chain of W468 is also depicted
in green. The cap analog is colored yellow and cyan for m
7Gp and GDP (ppG), respectively. (B) Enlarged view of the interface between PARN
RRM and the cap analog. Intra- and inter-molecular NOEs that were observed in NOESY spectra and used as restraints in the structure
determination are displayed with cyan and magenta lines, respectively. The surface of the PARN RRM is shown using the same color-code as in
Figure 2D. (C) Diagram of the interactions between the m
7GpppG cap analog and PARN RRM. Dashed lines indicate hydrogen bonds. Wavy lines
symbolize stacking interactions. (D) NMR dynamics studies for PARN RRM with and without the cap analog.
15N R1 (top) and
15N R2 (middle)
relaxation rates, and steady-state
1H–
15N NOE values (bottom) are shown for free PARN RRM (blue) and the PARN:RRM complex (red).
b-strands, helices, loops and turns are indicated schematically.
4762 Nucleic Acids Research, 2008, Vol. 36, No. 14N-terminus of the aA-helix, which are all located adjacent
to W468, became less mobile upon engaging the cap.
Mutational analysis of PARN RRM
NMR titration experiments indicated that W468
was clearly aﬀected upon cap binding, as shown
above (Figure 3). Moreover, the PARN:cap structure
suggested that some amino acid residues in the vicinity
of W468 are also involved in the cap recognition. To
further investigate the functionally important residues of
PARN RRM, we constructed four mutant proteins, in
which the surface-exposed residues ([0]K447A, K450A,
W468L and D471A) were altered, based on our structural
study. We then examined the cap-binding activities of
these mutant proteins by a pull-down assay. After an incu-
bation with m
7G(50)ppp-Sepharose, the bound proteins
were detected by SDS–PAGE (Figure 5). The pull-down
assay demonstrated that only the leucine substitution of
W468 signiﬁcantly decreased the interaction between
PARN RRM and the cap analog, whereas the other muta-
tions (K447A, K450A and D471A) displayed very little
inﬂuence on the cap binding (Figure 5). The result indi-
cated that the aromatic ring of W468 is directly responsi-
ble for the cap recognition and is a functionally critical
residue for the cap-binding activity of PARN RRM. This
conclusion coincides with those from our structural and
NMR dynamics studies, which showed that W468 is
located at the center of the cap-binding interface of
PARN RRM. This is also supported by recent data inde-
pendently obtained for the corresponding tryptophan resi-
due of human PARN RRM (53).
DISCUSSION
The stability ofthe aC-helix
Analyses of the C-terminal region from mouse PARN,
using NMR structures, dynamics studies, and deletion
mutagenesis, revealed that PARN RRM has unique struc-
tural features, as compared with the canonical RRM
family members. First, we showed that the fragment
spanning residues 430–516 is properly folded and suﬃcient
to bind to the cap (Figure 1B), while two other fragments
(residues 420–506 and 430–506) resulted in inclusion
body formation in E. coli cells during protein production.
These results led us to propose the important role of
the aC-helix (residues 502–509) for the stability and/or
solubility of PARN RRM. Actually, our structure of
PARN RRM revealed that residues Y502, V506 and
Y505 in the aC-helix participated in hydrophobic interac-
tions with the hydrophobic residues on the b-sheet surface
(red circles in Figure 1A). As a consequence, the aC-helix
completely covers the b1-strand and prevents the canoni-
cal RNA binding surface of the RRM from interacting
with other molecules (Figure 2A). Furthermore, we dem-
onstrated that the PARN RRM with and without the cap
analog is stable and well-structured, and that the position
of the aC-helix remains unchanged upon cap analog bind-
ing (Figures 2A, 4A and D). NMR dynamics data of
PARN RRM in the free and complex forms also revealed
that the residues involved in the hydrophobic core for-
mation between the aC-helix and the b-sheet are rigid in
both forms. Therefore, we conclude that the hydrophobic
residues within the aC-helix exert an important inﬂuence
on the stability and/or the solubility of the entire PARN
RRM, by hydrophobic interactions with the residues
within the b-sheet surface.
Many RRM-containing proteins are known to bind
with target RNA or protein molecules using the b-sheet
surface of RRM and the sequences ﬂanking RRM. One
such example is the well-known RNA-binding splicing
factor, U1A (54,55). U1A has an a-helical extension
termed helix C, which is connected with b4 of the RRM
by a short loop (six residues). This structural topology of
U1A is similar to that of the PARN RRM, except that the
aC-helix of the latter is connected immediately after b4
(Figure 1A). In the case of U1A in the free form, helix
C lies across the RNA-binding b-sheet surface and covers
a large part of it, to prevent nonspeciﬁc RNA from con-
tacting the RNA-binding b-sheet surface. Upon binding
to the target RNA, helix C is rearranged to interact
with another hydrophobic patch outside the b-sheet sur-
face. This rearrangement allows the amino acid residues
on the b-sheet surface, helix C, the b4-helix C loop and
the b2–b3 loop to cooperatively recognize the target
RNA. Correspondingly, the NMR dynamics data for
U1A,
15N T2 value (=1/R2), of the residues in the
two central strands of the b-sheet, within helix C, within
the b4-helix C loop and within the b2–b3 loop indicated
that these residues undergo conformational exchange pro-
cesses (56). Importantly, the U1A construct that lacks
helix C abolishes the RNA-binding activity, although it
is fully soluble (57). Therefore, it is also considered that
such a rearrangement of helix C, which regulates the
RNA-binding mode of U1A, may also be used in the
poly(A) tail recognition by PARN RRM. The interaction
between the b-sheet and the aC-helix, however, is very
strong in PARN RRM, on the basis of the relaxation
experiments. Thus, in the case of PARN RRM, high
energy may be needed to displace the aC-helix from the
b-sheet surface, and signiﬁcant stabilization must be
achieved upon poly(A) engagement. Actually, our NMR
WT
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Figure 5. Pull-down assays of PARN RRM point mutants. The wild-
type (WT) and mutant PARN RRM proteins were incubated with
m
7G(50)ppp-Sepharose 4B beads, and the bound proteins were eluted
by the addition of 2  SDS gel loading buﬀer. These supernatants were
collected, and the proteins were fractionated by 15–25% SDS–PAGE
and visualized by staining with Coomassie brilliant blue.
Nucleic Acids Research, 2008, Vol. 36, No. 14 4763titration experiments indicated that the 10-mer poly(A)
oligonucleotide, A10, is not a good substrate to over-
come such requirements and to rearrange the aC-helix
(Supplementary Figure S1), although the dissociation
constant for human PARN RRM and A10 binding
was reportedly smaller than  50nM (53). Thus, a longer
poly(A) might be required to achieve stronger binding,
since a 20-mer poly(A) reportedly binds to PARN RRM
more strongly (53). Alternatively, additional poly(A) bind-
ing regions outside PARN RRM may be necessary to
further stabilize the poly(A) binding.
Comparison ofcap recognition between PARN
RRMand CBP20
In the mammalian cell nucleus, the nuclear cap-binding
complex (CBC), which consists of the CBP20 and
CBP80 subunits, binds to the 50 cap of mRNAs (58,59).
Structural and binding studies of CBC with and without
the cap analog m
7GpppG showed that the CBP20 subunit
adopts the classical RRM fold (the babbab topology) and
binds directly to the cap in the presence of the CBP80
subunit (59–61). We performed a structural comparison
between our PARN RRM (babbaba) and CBP20
(babbab) (60,61), to assess the similarity between their
babbab regions. As shown in Figure 6, the cap recognition
site has also been identiﬁed in CBP20 (61), i.e. on the
b-sheet surface, which corresponds to the nucleotide bind-
ing site of the canonical RRMs (52). In the structure of
CBP20, the m
7G base is sandwiched between two tyrosine
residues, Y43 on the b-sheet surface and Y20 in the
N-terminal extension (60,61). Surprisingly, PARN RRM
has a distinctive cap recognition site, with respect to the
babbab topology (Figures 4A and 6A). On the b-sheet
surface of PARN RRM, the aromatic ring of H442
(corresponding to Y43 in CBP20) stacks with the phenol
ring of Y505 on the characteristic aC-helix by  –  stack-
ing interactions (Figures 2A and 6A), as described in
the Results. A comparison between the two cap-bound
structures of PARN RRM and CBP20 revealed that the
aromatic ring of Y505 on the aC-helix in PARN RRM
occupies the position corresponding to that of the m
7G
base in the CBP20-cap complex, even in the presence of
the cap analog (Figure 6A). Interestingly, the Y505 resi-
due is highly conserved among several species of PARN
RRMs (Figure 1A). This suggests that the stacking
between Y505 and H442 is a common feature of PARN
RRMs. This stacking prevents the aromatic residues on
the b-sheet surface of PARN RRM from interacting
with the cap.
The cap-binding specificity of PARN RRM
The speciﬁc binding of the cap to W468 of PARN RRM
was conﬁrmed by the mutation W468L, which indicated
that this tryptophan residue plays a central role in the cap
recognition (Figure 5). The other mutant proteins,
K447A, K450A and D471A, displayed scarcely any inﬂu-
ence on the interaction [0]with the cap, despite the fact
that these mutated residues are located in the vicinity of
W468 (Figure 5). Thus, changing the functional groups of
the side chains of these residues did not aﬀect the cap
binding by PARN RRM. These results for the mutational
analysis, combined with the description of possible hydro-
gen bonding interactions in the PARN RRM:cap complex
structure (Figure 4C), clearly explained how the cap recog-
nition is achieved. Indeed, K447 in the b1–aA loop and
D471 in the b2–b3 turn are directly involved in the
Figure 6. Structural comparison and sequence alignment between RRMs. (A) A superposition of the 3D structures of PARN RRM (red) with the
m
7GpppG cap analog (magenta), and the CBP20 complex (blue) with the m
7GpppG cap analog (cyan) (PDB ID 1H2T). Side chains discussed in the text
are labeled. The right panel shows an enlarged view of the boxed area in the left panel. (B) Structure-based sequence alignment between the RRMs of
CBP20, La protein and PARN. The well-conserved consensus sequences, RNP1 and RNP2, are boxed. Residues involved in b-strands and a-helices are
highlighted in cyan and red, respectively. The secondary structure elements observed in PARN RRM are shown at the top of the alignment.
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However, they utilized their backbone carbonyl oxygen
atoms for the recognition, instead of the functional
groups of their side chains. Therefore, the mutation of
these two residues displayed no detectable eﬀect on the
cap-binding activities. The backbone and side chain of
K450 lacked speciﬁc interactions with the cap. In addition
to the cases of K447 in the b1–aA loop and D471 in the
b2–b3 turn, the backbone atoms of W449 in the b1–aA
loop also participate in the cap binding (Figure 4C). Our
NMR dynamics data revealed that the internal motions of
the amino acid residues in the b2–b3 turn as well as those
at the N-terminus of the aA-helix, which are all located
adjacent to W468, were suppressed by the cap binding
(Figure 4D). This observation indicates that the residues
in the b1–aA loop, including the two residues K447 and
W449 mentioned above, play an auxiliary role in the cap
binding. Therefore, given that the 3D architecture of the
backbone atoms in the b1–aA loop and the b2–b3 turn is
formed by these residues, we conclude that the favorable
3D geometries of the loop and the turn are also important
for the speciﬁc recognition of the cap by PARN RRM.
Notably, the lengths of the b1–aA loop and the b2–b3
turn of PARN RRM are signiﬁcantly shorter than those
of the canonical RRMs (Figure 6B). This structural
feature probably ensures the backbone stability by redu-
cing the amplitude of the backbone motions, thereby
facilitating the speciﬁc interaction of PARN RRM with
the cap analog.
Full-length PARN reportedly deadenylates the
m
7GpppG-capped RNA better than the nonmethylated
GpppG- or GpppA-capped RNAs (19–21). Our NMR
titration and ITC data showed that PARN RRM has
stronger aﬃnity for the m
7GpppG than for the GpppG
and GpppA cap analogs. Therefore, we concluded that the
speciﬁc recognition of m
7G by PARN is indeed attributa-
ble to PARN RRM. These data revealed the importance
of the methylation. Interestingly, the intermolecular
hydrogen bond network between PARN RRM and the
m
7G, which were determined by our structural study,
could be formed by nonmethylated guanine as well.
Therefore, how could the m
7GpppG be discriminated
from the others? One would expect that the methyl
group is surrounded by many atoms and is involved in
van der Waals interactions with them. However, our
NOE data revealed that only W468 is in the proximity
of m
7G (Supplementary Figure S6), and the structure
showed that there is a  –  stacking interaction between
W468 and m
7G (Figure 4B). It is known that the methyla-
tion of guanine results in electron deﬁciency of the guanine
base  -orbitals, which favorably stack with the electron-
rich  -orbitals of the tryptophan indole (62). Thus, the
methylation of the guanine base is required to reinforce
the  –  stacking interaction. Taken together, our results
suggest that the stabilization of the  –  stacking interac-
tion is the main driving force of m
7GpppG recognition.
The Kd values between m
7GpppG and PARN RRM,
determined by our NMR titration and ITC experiments,
were in the micromolar to several tens of micromolar
range. These values are coincident with those obtained
by previous ﬂuorescence titration experiments (53).
The m
7GpppG cap structure is substantially recognized
by CBC in the nucleus and by eIF4E in the cytoplasm.
These Kd values are  10nM for CBC and 200nM for
eIF4E (60). Thus, the order of the aﬃnities for
m
7GpppG is: CBC>eIF4E>PARN RRM. As described
in the previous section and in Figure 6, CBP20, a subunit
of CBC, adopts a similar RRM fold to that of PARN
RRM. However, CBP20 uses a canonical RNA-binding
surface for strong binding to the m
7GpppG cap.
Intriguingly, considering the regulatory roles of PARN,
it is assumed that PARN RRM accommodates the
m
7GpppG cap on the unique binding surface on the
RRM fold in order to weaken the aﬃnity for the cap, as
compared with the binding by CBP20 and eIF4E.
Uniquestructural features of RRMs
Our NMR studies of PARN RRM revealed that the aro-
matic side chain of W468, which forms the cap-binding
center, protrudes from the b2 strand into the space
between the b2-strand and the aA-helix (Figure 2A). On
the other hand, the canonical RRM structures, such
as CBP20 (61), U1A (63,64), sex-lethal protein (65),
hnRNP D0 (66), Musashi1 (67) and PABP (68), do not
have a tryptophan residue at the position equivalent to
W468 (Figure 6B). The PARN RRM contains highly
conserved, bulky aromatic residues (F445 and W449)
(Figure 1A), and their side chains form the hydrophobic
core of the protein in the immediate vicinity of W468
(Figure 2A). In most RRMs, however, the positions cor-
responding to F445 and W449 in PARN RRM are occu-
pied by conserved aliphatic residues, which also contribute
to the formation of the hydrophobic core, e.g. a leucine
residue at the position of F445 (52) [the exception is
the RRM1 of La protein, which has phenylalanine at
the corresponding position (69)]. Consequently, since
the side chains of F445 and W449 of PARN RRM are
bulkier than those of aliphatic residues, these aromatic
side chains might invade the space where W468 would
be located. Therefore, W468 protrudes into the solvent,
leading to the unique interaction with the cap analog in
PARN RRM.
We have determined a vast number of RRM structures
(over 90 structures), which have been deposited in the
Protein Data Bank, as part of the structural genomics
project at RIKEN. Among them, the structure of an
RRM from the methenyltetrahydrofolate synthetase
domain-containing protein (MTHFSD, PDB ID 2E5J),
which adopts the canonical RRM fold, contains a trypto-
phan residue at the C-terminal end of the b2-strand,
the position equivalent to that of W468 in PARN
RRM (Supplementary Figure S7). This tryptophan resi-
due of MTHFSD RRM, however, was unable to engage
a nucleotide by a  –  stacking interaction, as in the case
of PARN RRM, since the indole ring of the tryptophan
is completely covered by a hydrophobic residue located at
the N-terminus of the aA-helix, and therefore is buried
in the hydrophobic core. This indicates that the existence
of a tryptophan residue at the sequence position equiva-
lent to that of W468 in PARN RRM does not necessarily
mean that it is the site for nucleotide engagement. It seems
Nucleic Acids Research, 2008, Vol. 36, No. 14 4765that the use of the indole ring of the corresponding tryp-
tophan residue for cap recognition is unique to the PARN
RRM, and that a tryptophan at the equivalent position in
the canonical RRMs would not be used for nucleotide-
binding, but for hydrophobic core formation.
The N-terminal region of PARN, consisting of the exo-
nuclease and R3H domains, is known to form a homodi-
mer that is directly involved in poly(A) engagement
(14,23). Our ﬁndings provide new information regarding
the cap recognition by PARN RRM. At the moment,
however, the functional signiﬁcance of the duplicated
cap-binding abilities and the exonuclease activities
remains unclear. It will be important to study the full-
length PARN protein to clarify its mechanisms in the
quality control and the translational regulation of mRNA.
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Supplementary Data are available at NAR Online.
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